JNJ · Johnson & Johnson Healthcare +0.9% on Oct 16
Updated Oct 17 · 10 feeds behind: FDA drug approvals, 1 day, and 9 more · Every feed →
On this page Show price chart The interactive JNJ chart (by TradingView) loads here.
Behind the stock
Recent disclosures Last 90 days · by disclosure date
Company insiders Insiders 0 buys6 sells
See who traded ↓ Company filings ↓ Is this unusual? ↓
Counts are trades, not people: one person's lots filed on the same day count as one trade. Trades can be disclosed weeks after they happen.
Our take 8 rules fired on JNJ
In short: none of these rules has solid or some evidence yet, so they show no clear lean on JNJ.
How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.
⚪ Not enough evidence · +2.9 pp vs similar · 51 signals on JNJ
⚪ Not enough evidence · +4.6 pp vs similar · 25 signals on JNJ · Open now
⚪ Not enough evidence · −0.1 pp vs similar · 15 signals on JNJ
All 8 rules ⚪ Not enough evidence · +8.6 pp vs similar · 9 signals on JNJ
⚪ Not enough evidence · +2.0 pp vs similar · 4 signals on JNJ
⚪ Not enough evidence · +2.5 pp vs similar · 2 signals on JNJ
⚪ Not enough evidence · +1.0 pp vs similar · 2 signals on JNJ
⚪ Not enough evidence · +1.2 pp vs similar · 1 signal on JNJ
🔒 The 0–100 score for JNJ, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on JNJ, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing → Compare with this company’s history
Is disclosure activity unusual? See how many different insiders or members of Congress reported purchases or sales of JNJ. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.
Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded
Insider purchases 0 filers recorded Short history Insider sales 0 filers recorded Short history Congress purchases 1 filer recorded Within earlier range Congress sales 0 filers recorded Within earlier range
Insider purchases
Short history
Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.
Latest 28 days 0
Earlier median 0
Earlier range 0–0 Distinct filers per 28 days Scale: 0–1
Oct 20, 2025 Oct 18, 2026
The history behind this view First stored company disclosure: Jun 12, 2026. Newest disclosure across this feed: Oct 16, 2026.
Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.
Insider sales
Short history
Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.
Latest 28 days 0
Earlier median 1
Earlier range 1–3 Distinct filers per 28 days Scale: 0–3
Oct 20, 2025 Oct 18, 2026
The history behind this view First stored company disclosure: Jun 12, 2026. Newest disclosure across this feed: Oct 16, 2026.
Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.
Congress purchases
Within earlier range
This count falls within the range of the 12 earlier comparable periods in this view.
Latest 28 days 1
Earlier median 0.5
Earlier range 0–2 Distinct filers per 28 days Scale: 0–2
Oct 20, 2025 Oct 18, 2026
The history behind this view First stored company disclosure: Aug 27, 2014. Newest disclosure across this feed: Oct 15, 2026.
Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.
Congress sales
Within earlier range
This count falls within the range of the 12 earlier comparable periods in this view.
Latest 28 days 0
Earlier median 1
Earlier range 0–3 Distinct filers per 28 days Scale: 0–3
Oct 20, 2025 Oct 18, 2026
The history behind this view First stored company disclosure: Aug 27, 2014. Newest disclosure across this feed: Oct 15, 2026.
Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.
Exact counts, dates and filings for all four categories Insider purchases · Short history Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.
Insider purchases: distinct filers in stored disclosures Period and filings Filers History Oct 20, 2025–Nov 16, 2025 — Unavailable Nov 17, 2025–Dec 14, 2025 — Unavailable Dec 15, 2025–Jan 11, 2026 — Unavailable Jan 12, 2026–Feb 8, 2026 — Unavailable Feb 9, 2026–Mar 8, 2026 — Unavailable Mar 9, 2026–Apr 5, 2026 — Unavailable Apr 6, 2026–May 3, 2026 — Unavailable May 4, 2026–May 31, 2026 — Unavailable Jun 1, 2026–Jun 28, 2026 0 Partial; excluded Jun 29, 2026–Jul 26, 2026 0 Within stored history Jul 27, 2026–Aug 23, 2026 0 Within stored history Aug 24, 2026–Sep 20, 2026 0 Within stored history Sep 21, 2026–Oct 18, 2026 Latest period 0 Within stored history
Insider sales · Short history Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 1; range: 1–3.
Insider sales: distinct filers in stored disclosures Period and filings Filers History Oct 20, 2025–Nov 16, 2025 — Unavailable Nov 17, 2025–Dec 14, 2025 — Unavailable Dec 15, 2025–Jan 11, 2026 — Unavailable Jan 12, 2026–Feb 8, 2026 — Unavailable Feb 9, 2026–Mar 8, 2026 — Unavailable Mar 9, 2026–Apr 5, 2026 — Unavailable Apr 6, 2026–May 3, 2026 — Unavailable May 4, 2026–May 31, 2026 — Unavailable Jun 1, 2026–Jun 28, 2026 1 Partial; excluded Jun 29, 2026–Jul 26, 2026 1 Within stored history Jul 27, 2026–Aug 23, 2026 3 Within stored history Aug 24, 2026–Sep 20, 2026 1 Within stored history Sep 21, 2026–Oct 18, 2026 Latest period 0 Within stored history
Congress purchases · Within earlier range This count falls within the range of the 12 earlier comparable periods in this view. Earlier median: 0.5; range: 0–2.
Congress purchases: distinct filers in stored disclosures Period and filings Filers History Oct 20, 2025–Nov 16, 2025 1 Within stored history Nov 17, 2025–Dec 14, 2025 1 Within stored history Dec 15, 2025–Jan 11, 2026 1 Within stored history Jan 12, 2026–Feb 8, 2026 0 Within stored history Feb 9, 2026–Mar 8, 2026 0 Within stored history Mar 9, 2026–Apr 5, 2026 1 Within stored history Apr 6, 2026–May 3, 2026 1 Within stored history May 4, 2026–May 31, 2026 0 Within stored history Jun 1, 2026–Jun 28, 2026 0 Within stored history Jun 29, 2026–Jul 26, 2026 2 Within stored history Jul 27, 2026–Aug 23, 2026 0 Within stored history Aug 24, 2026–Sep 20, 2026 0 Within stored history Sep 21, 2026–Oct 18, 2026 Latest period 1 Within stored history
Congress sales · Within earlier range This count falls within the range of the 12 earlier comparable periods in this view. Earlier median: 1; range: 0–3.
Congress sales: distinct filers in stored disclosures Period and filings Filers History Oct 20, 2025–Nov 16, 2025 2 Within stored history Nov 17, 2025–Dec 14, 2025 2 Within stored history Dec 15, 2025–Jan 11, 2026 1 Within stored history Jan 12, 2026–Feb 8, 2026 1 Within stored history Feb 9, 2026–Mar 8, 2026 0 Within stored history Mar 9, 2026–Apr 5, 2026 0 Within stored history Apr 6, 2026–May 3, 2026 3 Within stored history May 4, 2026–May 31, 2026 0 Within stored history Jun 1, 2026–Jun 28, 2026 1 Within stored history Jun 29, 2026–Jul 26, 2026 1 Within stored history Jul 27, 2026–Aug 23, 2026 2 Within stored history Aug 24, 2026–Sep 20, 2026 2 Within stored history Sep 21, 2026–Oct 18, 2026 Latest period 0 Within stored history
How to read this comparison The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.
Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.
These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.
Company timeline
What has been happening? May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.
Company filings May — Jun — Jul 7 Aug — Sep — Oct 2
Insiders May — Jun 2 Jul 2 Aug 11 Sep 3 Oct —
Public officials May 1 Jun 1 Jul 4 Aug 2 Sep 2 Oct 1
FDA & trials May 13 Jun 17 Jul 11 Aug 10 Sep 7 Oct 1
Owners & lobbying May 1 Jun — Jul 1 Aug — Sep — Oct 1
Company filings · Jul 2026 Filed Jul 29, 2026 Filed Jul 29, 2026 Filed Jul 28, 2026 Record date Jul 23, 2026 3 more on file are not listed here.
Company filings · Oct 2026 Filed Oct 13, 2026 Filed Oct 13, 2026 Insiders · Aug 2026 Disclosed Aug 18, 2026 Filed Aug 17, 2026 Disclosed Aug 14, 2026 Disclosed Aug 14, 2026 Filed Aug 13, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Filed Aug 6, 2026 Filed Aug 5, 2026 Insiders · Sep 2026 Disclosed Sep 4, 2026 Disclosed Sep 4, 2026 Filed Sep 2, 2026 Public officials · May 2026 Disclosed May 8, 2026 Public officials · Jun 2026 Disclosed Jun 18, 2026 Public officials · Jul 2026 Disclosed Jul 21, 2026 Disclosed Jul 21, 2026 Disclosed Jul 13, 2026 Disclosed Jul 6, 2026 Public officials · Aug 2026 Disclosed Aug 12, 2026 Disclosed Aug 5, 2026 Public officials · Sep 2026 Disclosed Sep 11, 2026 Disclosed Sep 10, 2026 Public officials · Oct 2026 Disclosed Oct 5, 2026 FDA & trials · May 2026 13 on file. This page lists only the newest records.
FDA & trials · Jun 2026 17 on file. This page lists only the newest records.
FDA & trials · Jul 2026 11 on file. This page lists only the newest records.
FDA & trials · Aug 2026 10 on file. This page lists only the newest records.
FDA & trials · Sep 2026 Record date Sep 30, 2026 Record date Sep 28, 2026 Record date Sep 25, 2026 Record date Sep 25, 2026 3 more on file are not listed here.
FDA & trials · Oct 2026 Record date Oct 6, 2026 Owners & lobbying · May 2026 Filed May 1, 2026 Owners & lobbying · Jul 2026 Record date Jul 5, 2026 Owners & lobbying · Oct 2026 Record date Oct 4, 2026 All 41 records in this snapshot Filed Oct 13, 2026 Filed Oct 13, 2026 Record date Oct 6, 2026 Disclosed Oct 5, 2026 Record date Oct 4, 2026 Record date Sep 30, 2026 Record date Sep 28, 2026 Record date Sep 25, 2026 Record date Sep 25, 2026 Disclosed Sep 11, 2026 Disclosed Sep 10, 2026 Disclosed Sep 4, 2026 Disclosed Sep 4, 2026 Filed Sep 2, 2026 Disclosed Aug 18, 2026 Filed Aug 17, 2026 Disclosed Aug 14, 2026 Disclosed Aug 14, 2026 Filed Aug 13, 2026 Disclosed Aug 12, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Disclosed Aug 7, 2026 Filed Aug 6, 2026 Filed Aug 5, 2026 Disclosed Aug 5, 2026 Filed Jul 29, 2026 Filed Jul 29, 2026 Filed Jul 28, 2026 Record date Jul 23, 2026 Disclosed Jul 21, 2026 Disclosed Jul 21, 2026 Disclosed Jul 21, 2026 Disclosed Jul 13, 2026 Disclosed Jul 6, 2026 Record date Jul 5, 2026 Disclosed Jun 18, 2026 Disclosed Jun 12, 2026 Disclosed May 8, 2026 Filed May 1, 2026 Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.
Put the amount in context
How big is this award for the business? Compare each recorded award total with one year of company sales. An award can span several years; this ratio measures scale, not additional annual revenue.
Mar 7, 2023 <0.1% of annual sales CHEMISTRY ANALYZERS, REAGENTS, SUPPLIES, TRAINING, MAINTENANCE $1M · Department of Defense Aug 12, 2022 <0.1% of annual sales DRY CHEMISTRY/IMMUNOCHEMISTRY SYSTEM $1.4M · Department of Veterans Affairs Mar 14, 2022 <0.1% of annual sales CHEMISTRY ANALYZER $1.4M · Department of Defense Oct 1, 2021 <0.1% of annual sales CHEMISTRY REAGENTS $1.3M · Department of Veterans Affairs Apr 1, 2021 <0.1% of annual sales CHEMISTRY $1.3M · Department of Veterans Affairs
<0.1% of one year’s sales
CHEMISTRY ANALYZERS, REAGENTS, SUPPLIES, TRAINING, MAINTENANCE
Award obligations · cumulative $1M
Company revenue · one year $94.2B
Both bars start at zero and share a dollar scale. The scale stays the same when you select another record.
Recorded award obligations $1,016,445
Recipient ORTHO-CLINICAL DIAGNOSTICS, INC
Record date Mar 7, 2023
Award ID HT941023F0063 The total may include changes made after the record date. The recipient may be a subsidiary of JNJ; the revenue comparison uses the whole company.
Inspect the original award or recipient record ↗
<0.1% of one year’s sales
DRY CHEMISTRY/IMMUNOCHEMISTRY SYSTEM
Award obligations · cumulative $1.4M
Company revenue · one year $94.2B
Both bars start at zero and share a dollar scale. The scale stays the same when you select another record.
Recorded award obligations $1,382,153
Recipient ORTHO-CLINICAL DIAGNOSTICS, INC
Record date Aug 12, 2022
Award ID 36C26222N0797 The total may include changes made after the record date. The recipient may be a subsidiary of JNJ; the revenue comparison uses the whole company.
Inspect the original award or recipient record ↗
<0.1% of one year’s sales
CHEMISTRY ANALYZER
Award obligations · cumulative $1.4M
Company revenue · one year $94.2B
Both bars start at zero and share a dollar scale. The scale stays the same when you select another record.
Recorded award obligations $1,357,664
Recipient ORTHO-CLINICAL DIAGNOSTICS, INC
Record date Mar 14, 2022
Award ID HT940622F0015 The total may include changes made after the record date. The recipient may be a subsidiary of JNJ; the revenue comparison uses the whole company.
Inspect the original award or recipient record ↗
<0.1% of one year’s sales
CHEMISTRY REAGENTS
Award obligations · cumulative $1.3M
Company revenue · one year $94.2B
Both bars start at zero and share a dollar scale. The scale stays the same when you select another record.
Recorded award obligations $1,262,604
Recipient ORTHO-CLINICAL DIAGNOSTICS, INC
Record date Oct 1, 2021
Award ID 36C26222F0027 The total may include changes made after the record date. The recipient may be a subsidiary of JNJ; the revenue comparison uses the whole company.
Inspect the original award or recipient record ↗
<0.1% of one year’s sales
CHEMISTRY
Award obligations · cumulative $1.3M
Company revenue · one year $94.2B
Both bars start at zero and share a dollar scale. The scale stays the same when you select another record.
Recorded award obligations $1,257,303
Recipient ORTHO-CLINICAL DIAGNOSTICS, INC
Record date Apr 1, 2021
Award ID 36C26221F0239 The total may include changes made after the record date. The recipient may be a subsidiary of JNJ; the revenue comparison uses the whole company.
Inspect the original award or recipient record ↗
The revenue used in this comparison $94.2B · Johnson & Johnson · Fiscal period Dec 30, 2024–Dec 28, 2025
Filed Feb 11, 2026. Latest available annual filing; may include restatements. It was not necessarily available when the contract began.
Annual revenue: $94,193,000,000 ↗
All 5 records and comparison values CHEMISTRY ANALYZERS, REAGENTS, SUPPLIES, TRAINING, MAINTENANCE $1,016,445 · <0.1% of annual revenue Source record ↗ DRY CHEMISTRY/IMMUNOCHEMISTRY SYSTEM $1,382,153 · <0.1% of annual revenue Source record ↗ CHEMISTRY ANALYZER $1,357,664 · <0.1% of annual revenue Source record ↗ CHEMISTRY REAGENTS $1,262,604 · <0.1% of annual revenue Source record ↗ CHEMISTRY $1,257,303 · <0.1% of annual revenue Source record ↗ Showing 5 of 10 distinct records in the recent snapshot, not all company contracts. Award totals are shown individually and are not added together. Obligations are government commitments, not cash received, profit, or a contract ceiling.
Who's buying and selling · last 90 days Company insiders 0 buys · 6 sells (10 filed lots) · $67.8M sold
▼ SELL Timothy Schmid EVP, WW Chair, MedTech JNJ Johnson & Johnson $6.2M disclosed Sep 4 · filed 2 days after the trade ▼ SELL Timothy Schmid EVP, WW Chair, MedTech JNJ Johnson & Johnson $3M disclosed Sep 4 · filed 2 days after the trade ▼ SELL Jennifer L Taubert EVP, WWC. Innovative Medicine JNJ Johnson & Johnson $4M disclosed Aug 18 · filed 1 day after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $5.5M disclosed Aug 14 · filed 1 day after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $26.7M disclosed Aug 14 · filed 1 day after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $10.8M disclosed Aug 7 · filed 2 days after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $1.7M disclosed Aug 7 · filed 2 days after the trade ▼ SELL Elizabeth Forminard EVP, Chief Legal Officer JNJ Johnson & Johnson $1.7M disclosed Aug 7 · filed 1 day after the trade ▼ SELL Elizabeth Forminard EVP, Chief Legal Officer JNJ Johnson & Johnson $2.4M disclosed Aug 7 · filed 1 day after the trade ▼ SELL Vanessa Broadhurst EVP, Global Corp Affairs JNJ Johnson & Johnson $5.8M disclosed Jul 21 · filed 1 day after the trade See every insider trade on JNJ → Filings & events Company filings (8-K) 54 Events the company must report to the SEC within days — results, deals, departures, restatements.
What it files 8-Ks about Quarterly or yearly results · item 2.02 13 Other events · item 8.01 8 Directors or officers joined, left or got new pay · item 5.02 5 Shared information with investors · item 7.01 3 Shareholder vote results · item 5.07 2 Changed its charter or bylaws · item 5.03 1 Filing red flags 99 Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.
FDA and clinical trials 530 Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.
Federal contracts 10 Contract awards from federal agencies, as USAspending lists them.
Lobbying 116 Lobbying reports filed with the Senate for the company.
$17.5M across 116 reports
Issues named in the most reports Oct 4, 2026 Lobbying for Brownstein Hyatt Farber Schreck, LLP Obo Johnson & Johnson ↗ by Richard Burness Jul 5, 2026 Lobbying for Brownstein Hyatt Farber Schreck, LLP Obo Johnson & Johnson ↗ by Richard Burness Apr 14, 2026 Lobbying for Brownstein Hyatt Farber Schreck, LLP Obo Johnson & Johnson ↗ by Richard Burness Jan 9, 2026 Lobbying for Brownstein Hyatt Farber Schreck, LLP Obo Johnson & Johnson ↗ by Richard Burness Oct 10, 2025 Lobbying for Brownstein Hyatt Farber Schreck, LLP Obo Johnson & Johnson ↗ by Richard Burness Planned insider sales (Form 144) 31 Notices insiders file before they sell certain shares, such as ones they got straight from the company.
6 in the last 90 days · 31 notices on file
The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.
5% owners (13D / 13G) 1 Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.
Push for changes, or just hold? Filed by Vanguard Capital Management LLC
Biggest named funds (13F) The largest JNJ holdings among the well-known funds whose quarterly 13F filings we read — opens here.
Every disclosed trade on JNJ ▲ BUY Lloyd Doggett Dem · House · TX JNJ Johnson & Johnson $1K–$15K disclosed Oct 5 · filed 27 days after the trade ▼ SELL John Boozman Rep · Senate · AR JNJ Johnson & Johnson $1K–$15K disclosed Sep 11 · filed 22 days after the trade ▼ SELL Thomas H. Kean Jr Rep · House · NJ JNJ Johnson & Johnson $1K–$15K disclosed Sep 10 · filed 14 days after the trade ▼ SELL Timothy Schmid EVP, WW Chair, MedTech JNJ Johnson & Johnson $6.2M disclosed Sep 4 · filed 2 days after the trade ▼ SELL Timothy Schmid EVP, WW Chair, MedTech JNJ Johnson & Johnson $3M disclosed Sep 4 · filed 2 days after the trade ▼ SELL Jennifer L Taubert EVP, WWC. Innovative Medicine JNJ Johnson & Johnson $4M disclosed Aug 18 · filed 1 day after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $5.5M disclosed Aug 14 · filed 1 day after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $26.7M disclosed Aug 14 · filed 1 day after the trade ▼ SELL Richard McCormick Rep · House · GA JNJ Johnson & Johnson $1K–$15K disclosed Aug 12 · filed 13 days after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $10.8M disclosed Aug 7 · filed 2 days after the trade ▼ SELL Joaquin Duato CEO and Chairman of the Board JNJ Johnson & Johnson $1.7M disclosed Aug 7 · filed 2 days after the trade ▼ SELL Elizabeth Forminard EVP, Chief Legal Officer JNJ Johnson & Johnson $1.7M disclosed Aug 7 · filed 1 day after the trade ▼ SELL Elizabeth Forminard EVP, Chief Legal Officer JNJ Johnson & Johnson $2.4M disclosed Aug 7 · filed 1 day after the trade ▼ SELL Tommy Tuberville Rep · Senate · AL JNJ Johnson & Johnson $15K–$50K disclosed Aug 5 · filed 645 days after the trade · late ▼ SELL Vanessa Broadhurst EVP, Global Corp Affairs JNJ Johnson & Johnson $5.8M disclosed Jul 21 · filed 1 day after the trade ▲ BUY Alan Armstrong Rep · Senate · OK JNJ Johnson & Johnson $1K–$15K disclosed Jul 21 · filed 113 days after the trade · late 2 rules fired ▲ BUY Alan Armstrong Rep · Senate · OK JNJ Johnson & Johnson $15K–$50K disclosed Jul 21 · filed 116 days after the trade · late 2 rules fired ▼ SELL Thomas H. Kean Jr Rep · House · NJ JNJ Johnson & Johnson $1K–$15K disclosed Jul 13 · filed 14 days after the trade ▲ BUY Lloyd Doggett Dem · House · TX JNJ Johnson & Johnson $1K–$15K disclosed Jul 6 · filed 27 days after the trade 1 rule fired ▼ SELL Thomas H. Kean Jr Rep · House · NJ JNJ Johnson & Johnson $1K–$15K disclosed Jun 18 · filed 16 days after the trade ▼ SELL Kathryn E Wengel EVP, Chief TO and Risk Officer JNJ Johnson & Johnson $2.4M disclosed Jun 12 · filed 1 day after the trade ▲ BUY Donald J Trump President JNJ Johnson & Johnson $15K–$50K disclosed May 8 · filed 58 days after the trade · late ▼ SELL John Boozman Rep · Senate · AR JNJ Johnson & Johnson $1K–$15K disclosed Apr 14 · filed 26 days after the trade ▼ SELL Thomas H. Kean Jr Rep · House · NJ JNJ Johnson & Johnson $1K–$15K disclosed Apr 13 · filed 18 days after the trade ▼ SELL Thomas H. Kean Jr Rep · House · NJ JNJ Johnson & Johnson $1K–$15K disclosed Apr 8 · filed 13 days after the trade See all 123 trades on JNJ → People & votes Which members of Congress traded JNJ, sponsored bills that touch it and voted on them — opens here.